Concepedia

H. Saegesser

HS

Statistics

Publications

4

Citations

370

H-Index

4

Active since

2005

Affiliations

University of Bern(Current)

H. Saegesser is an author at University of Bern specializing in antifibrotic therapy, fibrosis, and liver disease.

Publications per year

2005–2010

4

Publications

4

Low-dose oral rapamycin treatment reduces fibrogenesis, improves liver function, and prolongs survival in rats with established liver cirrhosis

Markus Neef, M Ledermann, H. Saegesser et al. · Journal of Hepatology · 2006 · 142 citations

, , +9

Potent antifibrotic activity of mTOR inhibitors sirolimus and everolimus but not of cyclosporine A and tacrolimus in experimental liver fibrosis

Eleonora Patsenker, Vreni Schneider, M Ledermann et al. · Journal of Hepatology · 2010 · 122 citations

, , +15

Oral imatinib treatment reduces early fibrogenesis but does not prevent progression in the long term

Markus Neef, M Ledermann, H. Saegesser et al. · Journal of Hepatology · 2005 · 92 citations

, , +4

Endothelial nitric oxide synthase is not essential for the development of fibrosis and portal hypertension in bile duct ligated mice

Abraham Koshy, Andrea De Gottardi, M Ledermann et al. · Liver International · 2005 · 14 citations · Full text

, , +14

1–4 of 4